Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

It’s Time! 3 Dodgy Pharma Stocks to Sell in February

Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.

Why Is Sunshine Biopharma (SBFM) Stock Down 17% Today?

Sunshine Biopharma stock is falling on Monday after the company revealed a delisting notice for SBFM shares and plans for a reverse split.

Why Is BioVie (BIVI) Stock Down 41% Today?

BioVie stock is falling on Monday after the company announced pricing for $21 million shares of BIVI stock in a public offering.

Why Is Ainos (AIMD) Stock Up 57% Today?

Ainos stock is rising higher on Monday as shares of AIMD experience heavy trading during pre-market hours today without clear news.

Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices

Underdogs stocks carry almost universal appeal. It’s one thing to go with the rest of the crowd. It’s quite another to take your time to…

3 Volatility-Busting, Low-Beta Stocks to Grab Now

These are the undervalued low-beta stocks to buy as they represent blue-chip names with robust cash flow outlook.

3 Top High-Yield Dividend Stocks to Fortify Your Portfolio: Q1 2024

One of the best ways to generate income and keep your portfolio safe is with high-yield dividend stocks in 2024.

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Why Is BioVie (BIVI) Stock Up 100% Today?

BioVie stock is rising higher with heavy trading of BIVI following positive clinical trial data for its Alzheimer’s and Parkinson’s drug.

Why Is GigCapital5 (GIA) Stock Down 61% Today?

GigCapital5 stock is falling on Friday as investors in GIA prepare for the company to go through with a SPAC merger next week.

3 Overhyped Stocks Every Smart Investor Should Ignore

Smart investors avoid overhyped stocks, as highlighted by three companies facing significant challenges in today's volatile market.

3 Speculative Stocks That Can Surge 100% in the Blink of an Eye

These are the speculative stocks to buy and represent companies with good fundamentals and impending catalysts for growth.

5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out

WW stock is falling lower after its earnings, adding that Oprah Winfrey would step down from the board of directors.

Forget Bonds, Grab These 3 Dividend Stocks for Retirement Income

Beating inflation is one thing; beating bond yields is another, and having both with double-digit upside is something only these stocks offer.

Don’t Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.

While the equities sector roars higher, it’s never a bad idea to consider stocks to buy for a down market. No, I’m not prognosticating an…

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today?

Investors in Enveric Biosciences are seeing massive gains today, as ENVB stock more than doubles on a huge uptick in trading volume.

3 Breakout Stocks Under $15 Set to Soar in the Next Year

Dive into three breakout stocks under $15 with growth from the consumer electronics, passenger airlines and pharmaceutical sectors.

Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?

Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results.

Why Is Societal CDMO (SCTL) Stock Up 133% Today?

Societal CDMO stock is heading higher on Thursday as CoreRX plans to acquire SCTL shares for $1.10 each through a tender offer.